Healthcare

Return the favour: South Korea looks to U.S. for COVID-19 vaccine aid

South Korea hopes the United States will help it tackle a shortage of coronavirus vaccine in return for test kits and masks Seoul sent to Washington earlier in the pandemic, the foreign minister said on Wednesday.

The government has drawn fire from the media for not doing enough to secure enough vaccines early, with just 3% of the population inoculated, due to tight global supply and limited access.

“We have been stressing to the United States that ‘A friend in need is a friend indeed,'” the minister, Chung Eui-yong, told reporters at the Kwanhun Club of South Korean journalists.

He said South Korea had airlifted Washington a large volume of coronavirus test kits and face masks in the early stages of the pandemic “in the spirit of the special South Korea-U.S. alliance,” despite tight domestic supply at the time.

“We are hoping that the United States will help us out with the challenges we are facing with the vaccines, based on the solidarity we demonstrated last year.”

The allies were in talks, added Chung, who also flagged South Korea’s potential contribution to preserving a global semiconductor supply chain U.S. President Joe Biden is keen to maintain.

Diplomatic efforts have not yielded any concrete steps, however, as the talks with Washington are still in an early stage, health ministry official Son Young-rae told reporters.

Opposition lawmaker Park Jin urged more aggressive vaccine diplomacy, calling for the government to invoke its free trade pact (FTA) with Washington to secure pharmaceutical products.

“The government needs to be more proactive,” Park told Reuters.

“The FTA provides us a legal base to demand (vaccines) as it stipulates the two countries’ commitment to promoting the development of, and facilitating access to, pharmaceutical products.”

The U.S. embassy in Seoul did not immediately reply to a Reuters’ request for comment.

About 1.77 million people in South Korea have had their first dose of the AstraZeneca Plc (AZN.L) or Pfizer (PFE.N) vaccines. The low rate compares with a 40% vaccination rate in the United States, according to Reuters data.

Tuesday’s 731 new coronavirus infections, up from 549 cases a day earlier, took South Korea’s tally to 115,926, with 1,806 deaths.

(Global vaccination tracker: https://graphics.reuters.com/world-coronavirus-tracker-and-maps/vaccination-rollout-and-access/)

Our Standards: The Thomson Reuters Trust Principles.

Source: https://www.reuters.com/world/asia-pacific/return-favour-south-korea-looks-us-covid-19-vaccine-aid-2021-04-21/

World Economic Magazine

Recent Posts

Judge Blocks New York Labor Law in Major Win for Amazon’s Workplace Policy Battle

Amazon secured a key early win as a federal judge blocked New York from enforcing…

2 hours ago

Enthuse Foundation Announced Finalists for 7th Annual Women Founders Pitch Competition

The Enthuse Foundation has revealed the finalists for its 7th Annual Women Founders Pitch Competition,…

2 hours ago

2nd Edition Model Risk Management, Canada

The Marcus Evans 2nd Edition Model Risk Management, Canada conference taking place in Toronto, Canada…

1 day ago

‘Grow With China’ Event Highlights Shanghai’s Expanding Role in Global Economic Growth

Economists say Shanghai is strengthening its role as China’s reform engine, accelerating innovation and global…

1 day ago

U.S. Consumers Plan to Spend Nearly $80 Billion During Black Friday

U.S. shoppers are set to spend nearly $80 billion this Black Friday and Cyber Monday,…

3 days ago

Waiken’s $450 Million Bet on Latin America: A Strategic Push into Connectivity and Content

Waiken has unveiled a US$450 million investment plan through 2031 to strengthen its entertainment and…

3 days ago